Experience with lymphatic mapping in breast cancer using isosulfan blue dye

Journal of Women's Health

Volumn 7, Issue 7, 1998, Pages 873-877

  Ratanawichitrasin, A ^a,b   Levy, L ^a   Myles, J ^a   Crowe, J P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFINE BLUE;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST METASTASIS; CLINICAL ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 37849187490     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1998.7.873     Document Type: Article

References (7)

1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391.
2. Veronesi U, Paganelli G, Galimberti V, et al. Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinical negative lymph-node. Lancet 1997; 349:1864.
3. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in patient with breast cancer. JAMA 1996;276:1818.
4. Statman RC, Jones RC, Cobot MC, Giuliano AE. Sentinel lymphadenectomy: A technique to eliminate axillary dissection in node-negative breast cancer. Proc Am Soc Clin Oncol 1996;15:125.
5. Ollila DW, Giuliano AE. Expert perspectives: Intraoperative lymphatic mapping and sentinel lymphadenectomy using isosulfan blue dye. Breast Dis 1998; 8:297.
6. Pickren JW. Significance of occult metastases: A study of breast cancer. Cancer 1961;41:1266.
7. Clare SE, Sener SF, Wilkens W, Goldschmidt R, Merkel D, Winchester DJ. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol 1997;4:447.